Peptide Research Blog
Stay informed with the latest research findings, comprehensive guides, and expert analysis on peptides and their applications in scientific research.
Latest Articles

Retatrutide Peptide: Triple GLP-1/GIP/Glucagon Agonist Guide (2026)
Retatrutide peptide (LY3437943) is the most potent weight loss compound in clinical development — a triple agonist targeting GLP-1, GIP, and glucagon receptors, showing up to 28.7% body weight loss in 68-week trials. Here's everything researchers need to know: mechanism, clinical data, dosing protocols, and sourcing.



